lorazepam and dacarbazine

lorazepam has been researched along with dacarbazine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Czarnetzki, BM; Kolde, G1
Bolton, JA; Bowcock, SJ; Kang, AA; Retsas, S; Stockdale, AD1

Reviews

1 review(s) available for lorazepam and dacarbazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for lorazepam and dacarbazine

ArticleYear
[High-dosage metoclopramide versus lorazepam in cytostatic-induced gastrointestinal side effects].
    Deutsche medizinische Wochenschrift (1946), 1983, Sep-02, Volume: 108, Issue:35

    Topics: Anti-Anxiety Agents; Dacarbazine; Gastrointestinal Diseases; Humans; Lorazepam; Metoclopramide

1983
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
    British medical journal (Clinical research ed.), 1984, Jun-23, Volume: 288, Issue:6434

    Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting

1984

Other Studies

2 other study(ies) available for lorazepam and dacarbazine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008